Monday to Sunday, including holidays: 8h - 20h
Phone number: 282 420 020
Av. S. João de Deus - Parque de Saúde da Misericordia de Portimão,
8500-508 Portimão
Opening Hours
Monday to Friday: 7am - 10pm
Saturdays, Sundays and Bank Holidays: 8 am - 10 pm
Urgent Care
Daily: 8am - 9pm
Clinical Analysis
Monday to Friday: 7am - 8pm
SaturdaySunday and Bank Holidays: 8am - 8pm
Av. General Humberto Delgado, Lote 7 7520-103 Sines
request appointment / exam
search
contacts
waiting times
Hospital Particular Alvor
00h21mAtendimento Urgente
Hospital Particular Gambelas
00h11mAtendimento Urgente
00h00mPediatria
Hospital Particular da Madeira
00h00mAtendimento Urgente
00h00mPediatria
Madeira Medical Center
00h00mAtendimento Urgente
waiting times
Hospital Particular Alvor
00h21mAtendimento Urgente
Hospital Particular Gambelas
00h11mAtendimento Urgente
00h00mPediatria
Hospital Particular da Madeira
00h00mAtendimento Urgente
00h00mPediatria
Madeira Medical Center
00h00mAtendimento Urgente
To make an appointment or book an examination, complete the form below with your personal details. We will subsequently send you an e-mail with confirmation/instructions.
Please note that information conserving Insurance agreements is merely informative. Therefore, please confirm that your particular Insurance Policy is contracted with us by completing the section “Observations” with your Insurance details.
Alternatively contact us on tel: 282 420 400* ( Algarve ) 269 630 370* ( Alentejo ) 291 00 33 00* (Madeira Island) or by email: callcenter@grupohpa.com
All information can also be obtained at the Reception counter of any one of our Hospitals or Clinics.
*(national landline)
Your request has been sent to the HPA Group successfully.
We will send send the availability of your appointment as soon as possible.
Thanks
Reumatologista
HPA Magazine 17
Generally speaking, non-live vaccines can be safely administered to immunosuppressed patients. Live vaccines are not recommended in case of high dosage immunosuppressive treatment, however, after a correct individual assessment of the risk/benefit ratio, they may be considered in select cases.
This assessment takes into account the patient’s inherent risk factors, such as age, type of immunosuppression to which he is subject and also the vaccine in question, for example, the yellow fever vaccine represents a greater risk than others, such as the herpes zoster vaccine.
As for vaccines outside the NVP, the recommendations for patients with systemic inflammatory rheumatic disease are:
• Annual flu vaccine and pneumococcal vaccine
• Hepatitis B vaccine in patients not immune to this virus
• Hepatitis A vaccine if traveling to an endemic area
• Vaccine against the human papilloma virus, for young adults not previously vaccinated
• Benefit/risk assessment for the herpes zoster vaccine in patients aged 60 years and over.
Rheumatic patients are at particular risk in the current pandemic context and vaccination against COVID-19 is recommended. In cases where the SARS-CoV-2 virus infection occurred before the first dose of the vaccine, immunosuppressed patients should follow the recommended programme from the 3rd month after infection.
An additional dose is indicated when the vaccination programme against COVID-19 has been carried out during a period of severe immunosuppression, namely treatment with leflunomide, rituximab, cyclosporine, cyclophosphamide, azathioprine, mycophenolate mofetil, methotrexate and high doses of corticosteroids (>10mg/day for at least 3 months or >20mg/day for at least 2 weeks). The additional dosage should consist of an mRNA vaccine, with a minimum interval of 3 months after the last dosage of the vaccination.
These recommendations should be systematically applied in daily clinical practice, in order to reduce the impact that infections have on the lives of rheumatic patients.